Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | MUSSALLEM MICHAEL A | Director | Sale+OE | 21,928 | $87.06 | $1,908,961.69 | -50.9% | → |
| 2024-02-01 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $78.29 | $567,993.95 | -27.4% | → |
| 2024-01-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 10,000 | $75.67 | $756,700.00 | -20.2% | → |
| 2024-01-05 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $72.98 | $2,142,089.00 | -45.0% | → |
| 2023-12-29 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 14,510 | $76.55 | $1,110,794.19 | -43.0% | → |
| 2023-12-15 | Chopra Daveen | CVP, TMTT | Sale+OE | 7,000 | $78.25 | $547,724.10 | -22.6% | → |
| 2023-12-13 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 8,658 | $71.86 | $622,163.88 | -3.9% | → |
| 2023-12-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 8,000 | $71.86 | $574,880.00 | -16.8% | → |
| 2023-12-13 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $74.62 | $2,190,043.08 | -26.0% | → |
| 2023-12-06 | Chopra Daveen | CVP, TMTT | Sale+OE | 3,500 | $70.00 | $245,005.60 | -12.8% | → |
| 2023-11-13 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 8,660 | $65.30 | $565,459.78 | -1.3% | → |
| 2023-11-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 6,000 | $65.30 | $391,780.22 | -6.8% | → |
| 2023-11-03 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $67.18 | $1,971,733.00 | -86.7% | → |
| 2023-10-31 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $62.66 | $454,568.55 | -27.4% | → |
| 2023-10-13 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 5,000 | $69.98 | $349,909.20 | -5.7% | → |
| 2023-10-13 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 8,660 | $70.00 | $606,197.98 | -2.0% | → |
| 2023-10-10 | Szyman Catherine M. | CVP, Critical Care | Sale+OE | 5,000 | $72.68 | $363,400.00 | -12.6% | → |
| 2023-10-03 | Chopra Daveen | CVP, TMTT | Sale+OE | 8,500 | $70.00 | $595,000.00 | -26.2% | → |
| 2023-10-02 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $68.84 | $2,020,454.00 | -86.7% | → |
| 2023-09-29 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $69.54 | $504,527.21 | -27.4% | → |
| 2023-09-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 4,500 | $73.71 | $331,695.00 | -10.2% | → |
| 2023-09-14 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 8,660 | $73.63 | $637,615.02 | -3.9% | → |
| 2023-09-08 | Szyman Catherine M. | CVP, Critical Care | Sale+OE | 5,000 | $76.00 | $380,000.00 | -12.6% | → |
| 2023-09-06 | Chopra Daveen | CVP, TMTT | Sale+OE | 8,500 | $76.07 | $646,609.45 | -26.2% | → |
| 2023-09-05 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $75.86 | $2,226,491.00 | -86.7% | → |
| 2023-08-31 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $77.79 | $564,366.45 | -27.4% | → |
| 2023-08-29 | Chopra Daveen | CVP, TMTT | Sell | 1,500 | $76.69 | $115,040.40 | -5.9% | → |
| 2023-08-14 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 6,421 | $79.30 | $509,185.30 | -2.9% | → |
| 2023-08-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 4,500 | $79.30 | $356,850.00 | -10.2% | → |
| 2023-08-10 | STONE HEISZ LESLIE | Director | Sell | 3,303 | $78.87 | $260,508.60 | -10.9% | → |
| 2023-08-09 | Szyman Catherine M. | CVP, Critical Care | Sale+OE | 5,000 | $78.64 | $393,185.00 | -12.6% | → |
| 2023-08-07 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $79.87 | $2,344,095.00 | -17.6% | → |
| 2023-07-31 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $84.35 | $611,959.25 | -27.4% | → |
| 2023-07-14 | Wood Larry L | Global President TAVR & Surg | Sale+OE | 8,660 | $92.94 | $804,843.08 | -3.9% | → |
| 2023-07-14 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 3,500 | $92.94 | $325,275.30 | -8.1% | → |
| 2023-07-10 | Szyman Catherine M. | CVP, Critical Care | Sale+OE | 5,000 | $90.52 | $452,600.00 | -12.6% | → |
| 2023-07-05 | MUSSALLEM MICHAEL A | Director | Sale+OE | 29,350 | $90.78 | $2,664,487.48 | -18.4% | → |
| 2023-06-30 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 7,255 | $93.27 | $676,673.85 | -27.4% | → |